La vendita allo scoperto per Village Farms Intl dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Village Farms Intl. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Village Farms Intl (NASDAQ:VFF) Azioni, Report sulle vendite allo scoperto

Village Farms Intl

Village Farms International Inc owns and operates intensive agricultural greenhouse facilities in British Columbia and Texas, where it produces, markets and sells tomatoes, bell peppers and cucumbers. Its wholly owned subsidiary, Pure Sunfarms, is a vertically integrated licensed producer and supplier of cannabis products sold to other licensed providers and provincial governments across Canada and internationally. The Company's wholly owned subsidiary, Balanced Health, develops and sells, cannabidiol (CBD) based products including ingestible, edible and topical applications. The Company has identified four operating segments - Produce, Cannabis-Canada, Cannabis-U.S. and Energy. The company makes majority of its revenue from the Produce segment.

Village Farms International, Inc. - Common Shares

Village Farms International Inc

Cryptocurrency markets are trading higher, with Bitcoin ETFs recording another strong trading day.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>&nbsp;$89,117.97</td>
<td>+3%</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>&nbsp;$3,279.31</td>
<td>-0.8%</td>
</tr>
<tr>
<td>Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td>&nbsp;$213.08</td>
<td>-2.4%</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>&nbsp;$0.3846</td>
<td>+20.5%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>&nbsp;$0.00002644&nbsp;&nbsp;</td>
<td>-3.3%</td>
</tr>
</tbody>
</table>
</figure>
Notable Statistics:
<ul>
<li>IntoTheBlock data shows large transaction volume increasing by 60.7% and daily active addresses growing by 17%. Transactions greater than $100,000 are up from 10,856 to 17,022 in a single day. Exchanges netflows are down by 410.7%.</li>
<li>Coinglass data reports 269,145 traders were liquidated in the past 24 hours for $938.44 million. Crypto long liquidations of $527.4 million were the highest since Aug. 5. Open interest spiked to $54.3 billion.</li>
</ul>
Notable Developments:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41907505/raoul-pal-predicted-bitcoin-to-hit-250000-but-he-thinks-ethereum-could-outperform-under-donald-trumps-administration">Raoul Pal Predicted Bitcoin To Hit $250,000—But He Thinks Ethereum Could Outperform Under Donald Trump&#8217;s Administration</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41910602/robinhood-ceo-vlad-tenev-operating-a-crypto-business-has-undeniable-advantages">Robinhood CEO Vlad Tenev: Operating A Crypto Business Has &#8216;Undeniable&#8217; Advantages</a></li>
<li><a href="https://www.benzinga.com/news/earnings/24/11/41914981/bitcoin-miners-hive-digital-hut-8-bitfarms-to-report-earnings-as-future-of-crypto-has-never-been-br">Bitcoin Miners Hive Digital, Hut 8, Bitfarms To Report Earnings As Future Of Crypto &#8216;Has Never Been Brighter&#8217;</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41899968/bitcoin-etfs-post-record-1-1-billion-inflow-what-is-going-on">Bitcoin ETFs Post Record $1.1 Billion Inflow: What Is Going On?</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41911120/the-german-government-sold-its-bitcoin-heres-how-much-it-missed-out-on">The German Government Sold Its Bitcoin—Here&#8217;s How Much It Missed Out On</a></li>
</ul>
Top Gainers:
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>AIOZ Network (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">AIOZ</a>)</td>
<td>&nbsp;$0.786</td>
<td>+33.3%</td>
</tr>
<tr>
<td>Bonk (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">BONK</a>)</td>
<td>&nbsp;$0.00003448&nbsp;&nbsp;</td>
<td>+27.8%</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td> $0.3846</td>
<td>+20.5%</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: With Bitcoin prices nearing the $90,000-mark, crypto trader The Moon <a href="https://x.com/TheMoonCarl/status/1856422249684971931">predicts</a> that if Bitcoin breaks to $90,000 today then &#8220;we will easily be at $100,000 tomorrow already.&#8221;
Crypto trader Pentoshi <a href="https://x.com/Pentosh1/status/1856378680991457588">pointed out</a> that in previous bull markets, Bitcoin experienced at least eight pullbacks over 20%, each resulting in sharp V-shaped recoveries within the same year. While he doesn't anticipate similar behavior for Bitcoin this time, it is expected for altcoins.
The trader recommends keeping cash on hand for &#8220;stink bids&#8221; during these dips, as such opportunities can lead to substantial gains. Pullbacks are seen as inevitable and often purge overleveraged positions from the market.
More Crypto Online noted that Bitcoin is holding at its current support at $85,210. The key support lies at the 50% retracement at $83,881. A drop below this level could invalidate the upward extension.
The trader sees target is one more peak between $92,000 and $95,000 before wave (4) potentially starts.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a>: Support still holds and this wave 4 is dancing on the 38.2% retracement at $85,210. Key support is the 50% retracement at $83,881 but a break below it might now lead to invalidation of the upside extension because wave (c) can be an ending diagonal and the structure is… <a href="https://t.co/hU6Vm4P9ZI">pic.twitter.com/hU6Vm4P9ZI</a>
&mdash; More Crypto Online (@Morecryptoonl) <a href="https://twitter.com/Morecryptoonl/status/1856388226056962421?ref_src=twsrc%5Etfw">November 12, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
What&#8217;s Next: The influence of&nbsp;<a href="https://www.benzinga.com/money/is-bitcoin-a-good-investment" target="_blank" rel="noreferrer noopener">Bitcoin as an institutional asset class</a>&nbsp;is expected to be thoroughly explored at Benzinga&#8217;s upcoming&nbsp;<a href="https://www.benzinga.com/events/digital-assets/agenda/" target="_blank" rel="noreferrer noopener">Future of Digital Assets</a>&nbsp;event on Nov. 19.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41912787/buckle-up-for-the-bull-markets-most-fun-phase-says-industry-expert-bitcoin-ethereum-dogecoin-about-to-enter-the-euphoria-stage">&#8216;Buckle Up&#8217; For The Bull Market&#8217;s &#8216;Most Fun Phase,&#8217; Says Industry Expert: Bitcoin, Ethereum, Dogecoin About To Enter The &#8216;Euphoria&#8217; Stage</a></li>
</ul>
Image: Shutterstock

$AIOZ

$BONK

$BTC

$DOGE

$ETH

$SHIB

$SOL

Bitcoin Nears $90,000, Dogecoin Soars, Ethereum Steady — Trader Eyes $100,000 Breakout If Milestone Hits Today

Amicus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOLD#NASDAQ">FOLD</a>) has been analyzed by 8 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Amicus Therapeutics and provided 12-month price targets. The average target is $17.5, accompanied by a high estimate of $21.00 and a low estimate of $15.00. This upward trend is evident, with the current average reflecting a 3.8% increase from the previous average price target of $16.86.
<img src="https://www.benzinga.com/files/images/story/2024/1731443470_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
A clear picture of Amicus Therapeutics's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Anupam Rama</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$17.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Debjit Chattopadhyay</td>
<td>Guggenheim</td>
<td>Raises</td>
<td>Buy</td>
<td>$15.00</td>
<td>$13.00</td>
</tr>
<tr>
<td>Kristen Kluska</td>
<td>Cantor Fitzgerald</td>
<td>Raises</td>
<td>Overweight</td>
<td>$21.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Tazeen Ahmad</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$15.00</td>
<td>$13.00</td>
</tr>
<tr>
<td>Jeffrey Hung</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$18.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Kristen Kluska</td>
<td>Cantor Fitzgerald</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$20.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Dennis Ding</td>
<td>Jefferies</td>
<td>Announces</td>
<td>Buy</td>
<td>$18.00</td>
<td>-</td>
</tr>
<tr>
<td>Anupam Rama</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$16.00</td>
<td>$17.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Amicus Therapeutics. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Amicus Therapeutics compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Amicus Therapeutics's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
For valuable insights into Amicus Therapeutics's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/FOLD/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Amicus Therapeutics analyst ratings.</a>
<h2>About Amicus Therapeutics</h2>
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.
<h3>Amicus Therapeutics: A Financial Overview</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Growth: Amicus Therapeutics displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately 36.73%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: Amicus Therapeutics's net margin excels beyond industry benchmarks, reaching -4.75%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Amicus Therapeutics's ROE excels beyond industry benchmarks, reaching -4.32%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Amicus Therapeutics's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -0.88%, the company may face hurdles in achieving optimal financial returns.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 2.49, caution is advised due to increased financial risk.
<h2>Analyst Ratings: What Are They?</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

FOLD

A Closer Look at 8 Analyst Recommendations For Amicus Therapeutics

Eastern Bankshares's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EBC#NYSE">EBC</a>) short percent of float has risen 4.37% since its last report. The company recently reported that it has 3.80 million shares sold short, which is 1.91% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.93 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Eastern Bankshares Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731443469_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Eastern Bankshares has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Eastern Bankshares's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Eastern Bankshares's peer group average for short interest as a percentage of float is 4.46%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

Looking Into Eastern Bankshares's Recent Short Interest

Norwegian Cruise Line's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NCLH#NYSE">NCLH</a>) short percent of float has fallen 10.95% since its last report. The company recently reported that it has 24.00 million shares sold short, which is 7.24% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.24 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Norwegian Cruise Line Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731443464_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Norwegian Cruise Line has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Norwegian Cruise Line's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Norwegian Cruise Line's peer group average for short interest as a percentage of float is 6.45%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

NCLH

How Is The Market Feeling About Norwegian Cruise Line?

Sweetgreen's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SG#NYSE">SG</a>) short percent of float has fallen 9.75% since its last report. The company recently reported that it has 15.51 million shares sold short, which is 20.64% of all regular shares that are available for trading. Based on its trading volume, it would take traders 6.59 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Sweetgreen Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731443459_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Sweetgreen has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Sweetgreen's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Sweetgreen's peer group average for short interest as a percentage of float is 9.43%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

(SG) - Analyzing Sweetgreen's Short Interest

In a bold projection that's sure to grab attention, veteran Wall Street strategist Ed Yardeni is calling for the S&amp;P 500 index to soar to 10,000 by the end of the decade due to a &#8220;Trump 2.0&#8221; boost after Donald Trump's <a href="https://www.benzinga.com/topic/2024-election">recent election victory</a>. 
Yardeni, a longtime market analyst, said Trump's return to the White House — alongside a likely Republican-controlled Congress — will bring in a major regime shift that's positive for U.S. stocks, the economy and corporate profits.
<h3 class="wp-block-heading">Why Yardeni Sees Trump 2.0 As Game-Changer For Markets</h3>
Yardeni's optimism stems from his belief that Trump's policies will accelerate economic growth and improve the fiscal picture.
"We believe Trump 2.0 represents a major regime change that's bullish for the economy and stocks," Yardeni said in a note to investors, adding that a business-friendly environment might even help to resolve ongoing geopolitical tensions, as evidenced by recent drops in oil and gold prices.
<h3 class="wp-block-heading">Rising Profit Expectations: 2025, 2026 EPS Revised Higher</h3>
To back up his S&amp;P 500 forecast, Yardeni adjusted his earnings expectations for the index's constituent companies.
He now expects 2025 earnings per share for the S&amp;P 500 to hit $285, up from his previous estimate of $275. His 2026 EPS projection has similarly risen, from $300 to $320.
While much of the recent growth in S&amp;P 500 earnings has been led by a handful of tech giants — the so-called &#8220;Magnificent 7&#8221; — Yardeni said he now predicts a broader strength ahead.
&#8220;We expect to see a broadening of the companies and industries for which analysts raise their sights in 2025,&#8221; he said.
<h3 class="wp-block-heading">Record Profit Margins: Tax Cuts, Deregulation in Focus</h3>
In Yardeni's view, Trump's anticipated policies could push corporate profit margins to new heights. He projects the S&amp;P 500 profit margin will rise to 13.9% in 2025 and 14.9% in 2026, levels he attributes to expected tax cuts, deregulation and productivity growth.
One key policy shift Yardeni said he expects is a reduction in the corporate tax rate from 21% to 15%, along with tax breaks for individual income from tips, overtime and Social Security.
He also anticipates a wave of regulatory rollbacks, especially after a recent Supreme Court ruling that empowers businesses to challenge regulatory overreach.
<h3 class="wp-block-heading">Adjusted Scenario Probabilities: Betting On The &#8216;Roaring 2020s&#8217;</h3>
Yardeni has increased the probability of his &#8220;Roaring 2020s&#8221; scenario, now assigning it a 55% chance, up from 50%. He sees a &#8220;1990s-style meltup&#8221; as a 25% possibility, while the chance of a &#8220;1970s-style geopolitical and/or domestic debt crisis&#8221; has dropped from 30% to 20%, he said. 
His reasoning? With Trump back in office, Yardeni said &#8220;a sooner end to current geopolitical crises&#8221; is possible, especially given recent trends in commodity markets, where oil and gold prices have softened.
The S&amp;P 500 Index — as tracked by the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) — is up nearly 27% year-to-date, on par with the performance seen in 2021.
Read Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41807254/trump-election-raises-odds-of-roaring-2020s-scenario-veteran-wall-street-investor-s">Trump Election Raises Odds Of &#8216;Roaring 2020s Scenario,&#8217; Veteran Wall Street Investor Says: How High Could US Stock Market Rise?</a>
<h3 class="wp-block-heading">Fed Rate Cuts: Fuel For S&amp;P 500 Meltup?</h3>
Yardeni is skeptical of recent Federal Reserve rate cuts, which he views as potentially over-stimulative. 
Following a 25-basis-point cut Nov. 7 and a 50-basis-point cut in September, Yardeni warns that continued easing could trigger a &#8220;meltup&#8221; in stocks and potentially rekindle inflation.
&#8220;If Fed officials continue to cut the FFR, they risk a rebound in price inflation rates and a meltup in the stock market,&#8221; the expert said.
<h3 class="wp-block-heading">New S&amp;P 500 Targets: 6,100 In 2024, 10,000 By 2029</h3>
With these bullish tailwinds in mind, Yardeni revised his S&amp;P 500 price targets sharply upward. He now sees the index reaching 6,100 by the end of 2024, 7,000 in 2025 and 8,000 in 2026.
By 2029, he expects the index to breach the 10,000 mark — a nearly 65% increase from today's levels.
If these projections hold, investors could be in for a banner decade of stock gains. But as with any market forecasts, only time will tell if &#8220;Trump 2.0&#8221; truly ushers in Yardeni's &#8220;roaring 2020s.&#8221;
Read Next:
<ul>
<li><a href="https://www.benzinga.com/federal-reserve/24/11/41900128/trump-vs-powell-dec-18-fed-meeting-sets-stage-for-new-tensions">Trump Vs. Powell: Dec. 18 Fed Meeting Sets Stage For New Tensions</a></li>
</ul>
Illustration created using artificial intelligence via Midjourney.

Analyst Color

Equities

Broad U.S. Equity ETFs

Politics

Econ #s

Economics

Federal Reserve

Markets

ETFs

Wall Street Veteran Predicts S&P 500 To Hit 10,000 By 2029: 'Roaring 2020s'

WIIM

GENI

Genius Sports shares are trading higher following Q3 financial results.

Financial Outlook
Genius Sports expects to generate Group Revenue of approximately $511 million and Group Adjusted EBITDA of approximately $86 million in 2024. This implies year-over-year Group Revenue and Adj. EBITDA growth of 24% and 61%, respectively. Genius Sports also expects to generate positive cash flow in the full year of 2024.
&nbsp;
<figure class="table"> 
<table>
<tbody>
<tr>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>$ in millions</td>
<td>&nbsp;</td>
<td colspan="2">Q1 2024A</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td colspan="2">Q2 2024A</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td colspan="2">Q3 2024A</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td colspan="2">Q4 2024E</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td colspan="2">FY 2024E</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Group Revenue</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>120</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>95</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>120</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>176</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>511</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Group Adjusted EBITDA</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>7</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>21</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>26</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>32</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>86</td>
<td>&nbsp;</td>
</tr>
</tbody>
</table>
</figure>

News

Guidance

Genius Sports Sees FY24 Revenue ~$511M Vs $509.95M Est.; Adj. EBITDA Of ~$86M

In the wake of Donald Trump's election victory, Wells Fargo &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>) shares have gained 12% to $72.67 in November, buoyed by optimism around pro-business policies anticipated under a Republican-led administration. 
Trump's promise to extend and expand the Tax Cuts and Jobs Act, including further corporate tax reductions, has renewed investor confidence in banking stocks like Wells Fargo, which stands to benefit from a <a href="https://www.benzinga.com/economics/macro-economic-events/24/11/41772701/trumps-historic-return-7-ways-his-second-term-could-impact-the-us-economy">friendlier tax environment</a> and reduced regulatory constraints.
What To Know: Wells Fargo, one of the United States&#8217; major banks, could experience improved profit margins if corporate tax rates are lowered further. Historically, the bank has also benefited from favorable regulatory changes under Republican administrations.
With the potential rollback of stringent environmental regulations, Wells Fargo's energy financing arm, which includes investments in fossil fuel projects, could see increased activity, further boosting revenue.
Additionally, the heightened inflation likely driven by Trump's proposed tariffs could prompt the Federal Reserve to maintain higher interest rates. For Wells Fargo, as for other banks, higher rates generally mean increased net interest margins, enhancing profitability on loans. 
Read Also: <a href="https://www.benzinga.com/news/global/24/11/41912971/stocks-fall-on-tariffs-fears-dollar-hits-6-month-peak-yen-tumbles-whats-driving-markets-tuesday">Stocks Fall On Tariffs Fears, Dollar Hits 6-Month Peak, Yen Tumbles: What&#8217;s Driving Markets Tuesday?</a>
<h2 class="wp-block-heading">How To Buy WFC Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Wells Fargo&#8217;s case, it is in the Financials sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, WFC has a 52-week high of $74.27 and a 52-week low of $40.53.

Wells Fargo Stock Is Up 12% This Month: What's Going On?

Genius Sports (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GENI#NYSE">GENI</a>) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $(0.01) by 600 percent. This is a 183.33 percent increase over losses of $(0.06) per share from the same period last year. The company reported quarterly sales of $120.20 million which beat the analyst consensus estimate of $118.94 million by 1.06 percent. This is a 18.16 percent increase over sales of $101.73 million the same period last year.

Earnings

Earnings Beats

Genius Sports Q3 EPS $0.05 Beats $(0.01) Estimate, Sales $120.20M Beat $118.94M Estimate

Nano Labs Shares Resume Trade Then Again Halt On Circuit Breaker To The Upside, Stock Now Up 146.5%

Stryve Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNAX#NASDAQ">SNAX</a>) is gearing up to announce its quarterly earnings on Wednesday, 2024-11-13. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Stryve Foods will report an earnings per share (EPS) of $-1.01.
Stryve Foods bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Past Earnings Performance</h3>
The company's EPS beat by $0.56 in the last quarter, leading to a 1.16% drop in the share price on the following day.

<a href="https://www.benzinga.com/quote/SNAX/earnings">To track all earnings releases for Stryve Foods visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

SNAX

Insights into Stryve Foods's Upcoming Earnings

FlexShopper (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FPAY#NASDAQ">FPAY</a>) will release its quarterly earnings report on Wednesday, 2024-11-13. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate FlexShopper to report an earnings per share (EPS) of $-0.15.
Anticipation surrounds FlexShopper's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Earnings History Snapshot</h3>
In the previous earnings release, the company beat EPS by $0.05, leading to a 0.0% drop in the share price the following trading session.

<img src="https://www.benzinga.com/files/images/story/2024/1731442539_0.png" alt="eps graph" />
<h3>FlexShopper Share Price Analysis</h3>
Shares of FlexShopper were trading at $1.21 as of November 11. Over the last 52-week period, shares are up 18.03%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<h3>Analysts' Perspectives on FlexShopper</h3>
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on FlexShopper.
FlexShopper has received a total of 1 ratings from analysts, with the consensus rating as Buy. With an average one-year price target of $2.5, the consensus suggests a potential 106.61% upside.
<h3>Analyzing Ratings Among Peers</h3>
The analysis below examines the analyst ratings and average 1-year price targets of and FlexShopper, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.
<h3>Snapshot: Peer Analysis</h3>
The peer analysis summary presents essential metrics for and FlexShopper, unveiling their respective standings within the industry and providing valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>FlexShopper</td>
<td>Buy</td>
<td>29.46%</td>
<td>$29.80M</td>
<td>-48.55%</td>
</tr>
</tbody>
</table>

Key Takeaway:
FlexShopper is positioned at the bottom for Revenue Growth among its peers. It also ranks at the bottom for Gross Profit. However, it is at the top for Return on Equity. Overall, FlexShopper's performance is mixed compared to its peers, with strengths in Return on Equity but weaknesses in Revenue Growth and Gross Profit.
<h3>Discovering FlexShopper: A Closer Look</h3>
FlexShopper Inc is a financial technology company engaged in providing certain types of durable goods to consumers on a lease-to-own basis and providing lease-to-own (LTO) terms to consumers of third-party retailers and e-tailers. Its products include electronics, computers, furniture, mattresses, cameras and camcorders, audio, musical instruments, health, fitness and sports, video games, homes, gardens and tools, appliances, and vacuums on a payment, lease basis. The firm generates a majority of its revenue by leasing its products. The company enables consumers utilizing its e-commerce marketplace to shop for brand-name electronics, home furnishings, and other durable goods on a lease-to-own (LTO) basis.
<h3>Unraveling the Financial Story of FlexShopper</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: FlexShopper displayed positive results in 3 months. As of 30 June, 2024, the company achieved a solid revenue growth rate of approximately 29.46%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Financials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: FlexShopper's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -8.49%, the company may face hurdles in effective cost management.
Return on Equity (ROE): FlexShopper's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of -48.55%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): FlexShopper's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -1.61%, the company may face hurdles in achieving optimal financial performance.
Debt Management: With a high debt-to-equity ratio of 29.24, FlexShopper faces challenges in effectively managing its debt levels, indicating potential financial strain.
<a href="https://www.benzinga.com/quote/FPAY/earnings">To track all earnings releases for FlexShopper visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

FPAY

An Overview of FlexShopper's Earnings

Editor&#8217;s note: This story has been updated to more accurately report a quote from Chris Christie that states he is not in favor of cannabis descheduling.
"The U.S. government has got to get its act together and decide what it really thinks on this issue," says <a href="https://www.benzinga.com/topic/chris-christie">Chris Christie</a>, former New Jersey governor and longtime conservative voice, addressing the state of cannabis in America under a new Trump administration. 
In an exclusive conversation with <a href="https://www.benzinga.com/cannabis">Benzinga Cannabis</a> facilitated by <a href="https://www.covers.com/politics/us-election-betting-odds">Covers.com</a>, Christie outlines his perspectives on the future of cannabis regulation and cryptocurrency adoption, framing both within a broader trend of deregulation he expects to see under Trump's leadership. As the country moves forward, Christie believes cannabis and crypto are poised to experience significant changes though each industry will need to navigate its own unique challenges.
<h2 class="wp-block-heading">Christie On Cannabis: &#8216;Trump Will Attempt To Deschedule&#8217;</h2>
Christie begins by tackling the complexities surrounding cannabis regulation, a topic he's been openly conservative about throughout his political career. Although he's traditionally opposed to federal legalization, Christie notes a potential shift under President-elect <a href="https://www.benzinga.com/topic/donald-trump">Donald Trump</a>. "What I suspect he would really like to do is get it downgraded by the DEA so that it&#8217;s not illegal," Christie says. Cannabis remains a Schedule I substance, making it federally illegal despite a growing wave of state-level legalization. For Christie, the legal status presents an obstacle for the industry, particularly regarding banking and financial services. "The trouble the cannabis industry has now is that a lot of people still won't do business with them, because the proceeds are tainted by the fact they are created through a drug that is illegal in the United States."
Christie suggests that descheduling cannabis—removing it from the DEA's list of controlled substances—could provide a workable solution. By changing its classification, he believes, the federal government could make way for legitimate business operations without directly endorsing legalization. "What I think Trump will attempt to do, which I don't favor, is change marijuana to a non-scheduled drug that wouldn&#8217;t be illegal, and then banks and other institutions would be more free to do business with cannabis store owners and entrepreneurs," he says. This stance marks a shift in Christie's approach, where he appears to reconcile his conservative views on cannabis with a pragmatic view of the industry's needs.
<h2 class="wp-block-heading">Christie On Crypto: Finding A &#8216;Sweet Spot&#8217;</h2>
Beyond cannabis, Christie also weighs in on another hot-button topic: cryptocurrency. Known for its volatility and potential for high returns, crypto has seen a significant uptick in adoption over recent years. With Trump heading to the White House, Christie predicts a favorable environment for crypto's continued expansion. "I think it will develop because he&#8217;ll not be in favor of doing a lot of regulating on it," he says, suggesting that Trump's general stance on deregulation could encourage further growth in the crypto sector.
However, Christie is quick to add a note of caution. "He&#8217;s got to be careful because when real people start to lose their money, and if that were to happen with crypto, they&#8217;re going to want the government to step in." For Christie, the challenge lies in striking a balance between fostering innovation and protecting the public. He stresses what he calls the "sweet spot" where regulation is minimal enough to allow growth, yet sufficient to shield investors from potential losses. "He&#8217;s got to try to find a sweet spot where he can regulate it enough so that grandma is not getting ripped off, but not so much that he puts a cap on its ability to grow and be a driver of America&#8217;s economy."
<h2 class="wp-block-heading">Are Christie&#8217;s Evolving Views A Reflection Of GOP&#8217;s Evolution?</h2>
Christie's pragmatic approach to cannabis and cryptocurrency reflects a broader trend within the GOP: a preference for state-led decision-making combined with cautious federal oversight. On cannabis, he continues to support a state-by-state approach, emphasizing that each state should have the freedom to regulate or prohibit cannabis as it sees fit. "The decision should be left to each individual state on cannabis regulation." This perspective aligns with Christie's conservative stance, although he acknowledges that a federal descheduling effort might make life easier for the industry.
With the potential <a href="https://www.benzinga.com/markets/cannabis/24/11/41828359/could-trumps-go-wild-on-health-invite-to-rfk-jr-drive-changes-for-cannabis-and-psychedelics">appointment of figures like RFK Jr. to key health positions</a> under a Trump administration, the regulatory landscape for both cannabis and crypto could evolve rapidly over the next four years. As Christie sees it, the approach Trump takes will shape not only the cannabis and crypto markets but also public sentiment and investor confidence. His vision, rooted in deregulation with a careful dose of oversight, aims to balance the drive for innovation with a commitment to public safety—a delicate act in today's rapidly shifting political and economic landscape.
Photo via Shutterstock

Cannabis

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Exclusives

Interview

EXCLUSIVE: Chris Christie Says Trump Will Remove Federal Restrictions On Marijuana, Find 'Sweet Spot' For Crypto Regulation (UPDATED)

Nano Labs Shares Halted On Circuit Breaker To The Upside, Stock Now Up 123.7%

Associated Cap Gr's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AC#NYSE">AC</a>) short percent of float has fallen 58.82% since its last report. The company recently reported that it has 6 thousand shares sold short, which is 0.63% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.0 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Associated Cap Gr Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731442304_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Associated Cap Gr has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Associated Cap Gr's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Associated Cap Gr's peer group average for short interest as a percentage of float is 2.37%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Looking Into Associated Cap Gr's Recent Short Interest

Williams Companies's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMB#NYSE">WMB</a>) short percent of float has fallen 15.62% since its last report. The company recently reported that it has 17.67 million shares sold short, which is 1.62% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.17 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Williams Companies Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731442299_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Williams Companies has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Williams Companies's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Williams Companies's peer group average for short interest as a percentage of float is 4.26%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About Williams Companies?

WR Berkley's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRB#NYSE">WRB</a>) short percent of float has fallen 23.47% since its last report. The company recently reported that it has 4.49 million shares sold short, which is 1.5% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.72 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>WR Berkley Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731442294_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for WR Berkley has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing WR Berkley's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, WR Berkley's peer group average for short interest as a percentage of float is 1.73%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About WR Berkley?

https://ppubs.uspto.gov/pubwebapp/external.html?q=(12138033).pn<img src="https://pbs.twimg.com/media/GcNLzzIWUAA9vxq?format=jpg&amp;name=900x900" alt="Image" />

Biotech

General

CHEK

Check-Cap Granted US Patent #12138033 For "SYSTEM AND METHOD FOR POLYP AND COLON CANCEROUS GROWTH DETECTION THROUGH CAPSULE DYNAMICS". Also 'Uses a Neural Network to Determine a Probability Score'.

BILL

BILL Holdings shares are trading higher on continued strength after the company last week reported better-than-expected Q1 financial results and issued FY25 guidance above estimates. Goldman Sachs maintained a Neutral rating on the stock but raised its PT from $60 to $77.

Village Farms Offers Cannabis Investors A Fantastic Opportunity

Village Farms International receives Nasdaq non-compliance notification

Village Farms International (VFF) has released an update. Village Farms International has received a notification from Nasdaq that its stock price ...

Village Farms Faces Nasdaq Compliance Challenge

Tilray Brands Is Still Priced Too High

Village Farms (VFF) was one of 25 participants selected to participate in the Drug Enforcement Administration's upcoming Administrative Law Judge h...

Village Farms to testify at marijuana rescheduling hearing

Village Farms International (VFF) has released an update. Village Farms International has been selected as the sole cannabis industry operator to p...

Village Farms to Testify at DEA Marijuana Hearing

Village Farms GAAP EPS of -$0.01 beats by $0.02, revenue of $83.37M beats by $2.8M

In a report released today, Eric Des Lauriers from Craig-Hallum maintained a Buy rating on Village Farms International (VFF – Research Report). The...

Comments

Village Farms Intl

Vendite allo scoperto

Village Farms Intl (NASDAQ:VFF) Azioni, Report sulle vendite allo scoperto

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO